ATE517096T1 - Verfahren zur herstellung von aminopyrimidinen - Google Patents
Verfahren zur herstellung von aminopyrimidinenInfo
- Publication number
- ATE517096T1 ATE517096T1 AT05729737T AT05729737T ATE517096T1 AT E517096 T1 ATE517096 T1 AT E517096T1 AT 05729737 T AT05729737 T AT 05729737T AT 05729737 T AT05729737 T AT 05729737T AT E517096 T1 ATE517096 T1 AT E517096T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- compound
- formula
- aminopyrimidines
- producing
- Prior art date
Links
- 150000005005 aminopyrimidines Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 abstract 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 238000005984 hydrogenation reaction Methods 0.000 abstract 1
- 238000005580 one pot reaction Methods 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0401001A SE0401001D0 (sv) | 2004-03-31 | 2004-03-31 | Chemical process |
| PCT/GB2005/001188 WO2005095358A2 (en) | 2004-03-31 | 2005-03-29 | Process for the preparation of aminopyrimidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE517096T1 true ATE517096T1 (de) | 2011-08-15 |
Family
ID=32294337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05729737T ATE517096T1 (de) | 2004-03-31 | 2005-03-29 | Verfahren zur herstellung von aminopyrimidinen |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7799914B2 (de) |
| EP (2) | EP1751117B1 (de) |
| JP (1) | JP5059599B2 (de) |
| KR (1) | KR101164265B1 (de) |
| CN (2) | CN101851212A (de) |
| AT (1) | ATE517096T1 (de) |
| AU (1) | AU2005227727B2 (de) |
| BR (1) | BRPI0509323A (de) |
| CA (1) | CA2560094C (de) |
| CY (1) | CY1111847T1 (de) |
| DK (1) | DK1751117T3 (de) |
| ES (1) | ES2368069T3 (de) |
| HR (1) | HRP20110658T1 (de) |
| IL (1) | IL177998A (de) |
| NO (1) | NO20064117L (de) |
| NZ (2) | NZ587999A (de) |
| PL (1) | PL1751117T3 (de) |
| PT (1) | PT1751117E (de) |
| SE (1) | SE0401001D0 (de) |
| SG (1) | SG151311A1 (de) |
| SI (1) | SI1751117T1 (de) |
| WO (1) | WO2005095358A2 (de) |
| ZA (1) | ZA200607708B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401001D0 (sv) * | 2004-03-31 | 2004-03-31 | Astrazeneca Ab | Chemical process |
| TWI385156B (zh) * | 2006-02-13 | 2013-02-11 | Lonza Ag | 5-(芳基-二氮烯基)-4,6-二鹵-嘧啶之還原作用 |
| KR101669297B1 (ko) | 2008-09-09 | 2016-10-25 | 아스트라제네카 아베 | [1S-[1-알파,2-알파,3-베타(1S*,2R*),5-베타]]-3-[7-[2-(3,4-디플루오로페닐)-사이클로프로필아미노]-5-(프로필티오)-3H-1,2,3-트리아졸로[4,5-d]피리미딘-3-일]-5-(2-하이드록시에톡시)사이클로펜탄-1,2-디올의 제조 방법 및 그 중간체 |
| EP2305376A1 (de) * | 2009-09-23 | 2011-04-06 | Lonza Ltd. | Prozess und Katalysator zur katalytischen Hydrierung von aromatischen und heteroaromatischen Nitroverbindungen |
| US9233966B2 (en) | 2012-04-05 | 2016-01-12 | Dr. Reddy's Laboratories Limited | Preparation of ticagrelor |
| CN103130726A (zh) * | 2013-02-07 | 2013-06-05 | 许学农 | 替卡格雷中间体4,6-二氯-2-(丙巯基)-5-氨基嘧啶的制备方法 |
| WO2014206187A1 (zh) | 2013-06-24 | 2014-12-31 | 苏州明锐医药科技有限公司 | 替卡格雷及其中间体的制备方法 |
| CA2921956C (en) | 2013-08-22 | 2021-10-19 | Genentech, Inc. | Process for preparing (r)-5-bromo-4-(3-amino)piperidin-1-yl)-3-(cyclopropanecarboxamido)-1h-pyrrolo[2,3-b]pyridine |
| CN103588712B (zh) * | 2013-11-08 | 2016-06-08 | 南京欧信医药技术有限公司 | 一种嘧啶类化合物及其制备方法、和应用 |
| CN103923020A (zh) * | 2014-04-02 | 2014-07-16 | 黄河三角洲京博化工研究院有限公司 | 一种2-丙硫基-4,6-二氯-5-氨基嘧啶的制备方法 |
| CN105020602B (zh) * | 2014-04-30 | 2017-12-08 | 欧普照明股份有限公司 | 一种led灯 |
| CN103992277A (zh) * | 2014-05-16 | 2014-08-20 | 苏州天马精细化学品股份有限公司 | 一种替卡格雷中间体4,6-二氯-5-氨基-2-丙硫基嘧啶的制备方法 |
| CN105294573B (zh) * | 2015-06-16 | 2018-07-10 | 厦门医学院 | 一种合成4,6-二氯-2-(丙硫基)-5-氨基嘧啶的方法 |
| CN116283796A (zh) * | 2023-02-14 | 2023-06-23 | 上海汇伦医药股份有限公司 | 一种循环催化氢化硝基化合物的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0579643A1 (de) * | 1991-04-06 | 1994-01-26 | FISONS plc | ATP-Analogen |
| CZ289721B6 (cs) | 1995-05-19 | 2002-03-13 | Syngenta Participations Ag | Způsob katalytické hydrogenace aromatických nitrosloučenin |
| AR017014A1 (es) | 1997-07-22 | 2001-08-22 | Astrazeneca Ab | Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos |
| TWI229674B (en) | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
| GB0013488D0 (en) * | 2000-06-02 | 2000-07-26 | Astrazeneca Ab | Chemical compound |
| US6818720B2 (en) * | 2001-11-08 | 2004-11-16 | Degussa Ag | Supported hydrogenating catalyst in powder form |
| SE0401001D0 (sv) * | 2004-03-31 | 2004-03-31 | Astrazeneca Ab | Chemical process |
-
2004
- 2004-03-31 SE SE0401001A patent/SE0401001D0/xx unknown
-
2005
- 2005-03-29 AU AU2005227727A patent/AU2005227727B2/en not_active Ceased
- 2005-03-29 PL PL05729737T patent/PL1751117T3/pl unknown
- 2005-03-29 AT AT05729737T patent/ATE517096T1/de active
- 2005-03-29 SG SG200902108-0A patent/SG151311A1/en unknown
- 2005-03-29 BR BRPI0509323-6A patent/BRPI0509323A/pt not_active Application Discontinuation
- 2005-03-29 EP EP05729737A patent/EP1751117B1/de not_active Expired - Lifetime
- 2005-03-29 HR HR20110658T patent/HRP20110658T1/hr unknown
- 2005-03-29 SI SI200531366T patent/SI1751117T1/sl unknown
- 2005-03-29 CN CN201010206146A patent/CN101851212A/zh active Pending
- 2005-03-29 WO PCT/GB2005/001188 patent/WO2005095358A2/en not_active Ceased
- 2005-03-29 KR KR1020067021443A patent/KR101164265B1/ko not_active Expired - Fee Related
- 2005-03-29 CN CN2005800102841A patent/CN1938284B/zh not_active Expired - Lifetime
- 2005-03-29 NZ NZ587999A patent/NZ587999A/en not_active IP Right Cessation
- 2005-03-29 US US10/599,377 patent/US7799914B2/en not_active Expired - Fee Related
- 2005-03-29 CA CA2560094A patent/CA2560094C/en not_active Expired - Fee Related
- 2005-03-29 PT PT05729737T patent/PT1751117E/pt unknown
- 2005-03-29 NZ NZ550128A patent/NZ550128A/en not_active IP Right Cessation
- 2005-03-29 JP JP2007505626A patent/JP5059599B2/ja not_active Expired - Fee Related
- 2005-03-29 DK DK05729737.6T patent/DK1751117T3/da active
- 2005-03-29 ES ES05729737T patent/ES2368069T3/es not_active Expired - Lifetime
- 2005-03-29 EP EP10179703A patent/EP2308853A1/de not_active Withdrawn
-
2006
- 2006-09-11 IL IL177998A patent/IL177998A/en not_active IP Right Cessation
- 2006-09-13 NO NO20064117A patent/NO20064117L/no not_active Application Discontinuation
- 2006-09-14 ZA ZA200607708A patent/ZA200607708B/en unknown
-
2010
- 2010-08-31 US US12/871,993 patent/US20100324289A1/en not_active Abandoned
-
2011
- 2011-09-15 CY CY20111100890T patent/CY1111847T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE533775T1 (de) | Verfahren zur herstellung von 17-vinyl-triflaten als intermediate | |
| CY1111847T1 (el) | Διαδικασια για την παρασκευη αμινοπυριμιδινων | |
| ATE556085T1 (de) | Phosphoramiditverbindung und verfahren zur herstellung von oligo-rna | |
| ATE496928T1 (de) | Bisacylphosphane und ihre verwendung als photoinitiatoren, verfahren zur herstellung von acylphosphanen | |
| DE60316006D1 (de) | Verfahren zur herstellung kondensierter oxazinone aus einer aromatischen ortho-aminocarbonsäure und einer carbonsäure in gegenwart eines sulfonylchlorids und pyridin | |
| ATE506356T1 (de) | Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen | |
| ATE442363T1 (de) | Verfahren zur herstellung von pyridinverbindungen | |
| ATE531702T1 (de) | Verfahren zur herstellung von epoxytriazolderivat und zwischenprodukten dafür | |
| DE60238367D1 (de) | Asymmetrischer Kupferkomplex und dessen Verwendung in Cyclopropanierungsreaktion | |
| DE50204181D1 (de) | Phthalsäurediamide, ein verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel | |
| ATE521594T1 (de) | Verfahren zur herstellung von chinolin-3- carbonsäureverbindungen | |
| ATE501120T1 (de) | Verfahren zur herstellung von isoindolderivaten | |
| ATE447567T1 (de) | Verfahren zur herstellung von tryptase- inhibitoren | |
| ATE459617T1 (de) | Verfahren zur herstellung von pyridinmethylsulphinylverbindungen | |
| ATE363460T1 (de) | Verfahren zur herstellung von fluorhalogenalkanen | |
| ATE419230T1 (de) | Verfahren zur herstellung von 2,6-dihalo-para- trifluoromethylanilin | |
| ATE469141T1 (de) | Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten | |
| ATE353877T1 (de) | Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern | |
| ATE399757T1 (de) | Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol | |
| ATE423096T1 (de) | Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten | |
| ATE492523T1 (de) | Verfahren zur herstellung von halogensubstituiertem benzoldimethanol | |
| ATE380183T1 (de) | Verfahren zur herstellung von phenyltetrazolderivaten | |
| ATE513824T1 (de) | Verfahren zur herstellung von isothiocyanato-2,2- difluorbenzo-(1,3)-dioxolen | |
| DE602005022213D1 (de) | Verfahren zur herstellung von phenyl-2-pyrimidinyl-ketonen und neuen zwischenprodukten daraus | |
| ATE367384T1 (de) | Verfahren zur herstellung von alkoxycarbonylmethoxy-cyclopentanen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1751117 Country of ref document: EP |